This book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechnology from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialization of biological inventions.
The author also considers the contradictions between the Supreme Court of Canada rulings in respect of the Harvard oncomouse, and genetically modified canola. He explores law, policy, and practice in both Australia and New Zealand in respect to gene patents and non-coding DNA. This study charts the rebellion against the European Union Biotechnology Directive - particularly in respect of Myriad Genetics' BRCA1 and BRCA2 patents, and stem cell patent applications. The book also considers whether patent law will accommodate frontier technologies - such as bioinformatics, haplotype mapping, proteomics, pharmacogenomics, and nanotechnology.
Intellectual Property and Biotechnology will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists.
"Sinopsis" puede pertenecer a otra edición de este libro.
Matthew Rimmer, Professor of Intellectual Property and Innovation Law, Faculty of Business and Law, Queensland University of Technology (QUT), Australia
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. pp. 392. Nº de ref. del artículo: 5325532
Cantidad disponible: 1 disponibles
Librería: Books Puddle, New York, NY, Estados Unidos de America
Condición: New. pp. 392. Nº de ref. del artículo: 262555139
Cantidad disponible: 1 disponibles
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Condición: New. pp. 392. Nº de ref. del artículo: 182555145
Cantidad disponible: 1 disponibles
Librería: Corner of a Foreign Field, Tokyo, TOKYO, Japon
Soft cover. Condición: Very Good. No Jacket. 2011.Softcover.Very good condition.Ships from Japan.Usually ships in 1-2 working days. Nº de ref. del artículo: 4159
Cantidad disponible: 1 disponibles
Librería: Anybook.com, Lincoln, Reino Unido
Condición: Poor. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In poor condition, suitable as a reading copy. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,700grams, ISBN:9780857933706. Nº de ref. del artículo: 3986890
Cantidad disponible: 1 disponibles
Librería: Anybook.com, Lincoln, Reino Unido
Condición: Fair. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In fair condition, suitable as a study copy. Library sticker on front cover. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,700grams, ISBN:9780857933706. Nº de ref. del artículo: 3986891
Cantidad disponible: 1 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: FW-9780857933706
Cantidad disponible: 8 disponibles
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
Paperback. Condición: New. This book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechnology from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialization of biological inventions.The author also considers the contradictions between the Supreme Court of Canada rulings in respect of the Harvard oncomouse, and genetically modified canola. He explores law, policy, and practice in both Australia and New Zealand in respect to gene patents and non-coding DNA. This study charts the rebellion against the European Union Biotechnology Directive - particularly in respect of Myriad Genetics' BRCA1 and BRCA2 patents, and stem cell patent applications. The book also considers whether patent law will accommodate frontier technologies - such as bioinformatics, haplotype mapping, proteomics, pharmacogenomics, and nanotechnology.Intellectual Property and Biotechnology will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists. Nº de ref. del artículo: LU-9780857933706
Cantidad disponible: 4 disponibles
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
Condición: new. Nº de ref. del artículo: cd189e09f2e2712ae84fa262cafc6c1f
Cantidad disponible: 8 disponibles
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condición: New. 2011. Reprint. Paperback. . . . . . Nº de ref. del artículo: V9780857933706
Cantidad disponible: 1 disponibles